semaglutide clinical trials near me Novo Nordisk announced headline results from STEP UP, a phase IIIb trial investigating subcutaneous 7.2 mg for obesity New Wegovy clinical trial finds
Description
Polonsky KS, Pugh W, Jaspan JB, Cohen DM, Karrison T, Tager HS, Rubenstein AH
It can be effective, but it is not suitable for everyone
It delves into the mechanistic role of PL in obesity, examines the efficacy and limitations of existing inhibitors, and discusses the potential of emerging treatments
One method leverages hydrazine chemistry and peptide coupling, where the side chain of the aza-amino acid is built on a hydrazine derivative before coupling with a proteogenic amino acid (Scheme a)
K.VarnicM.LeL
10.1038/s41591-024-03018-2 142 ScheenA
